新時代の価値創造へグローバルの総合力で革新的なパフォーマンスを IQVIAは、グローバルの先端知⁠識と日本ローカルの深い知⁠見を組み合わせた屈指の専門性に、データ・分析力・テクノロジーを掛け合わせた革新的なアプローチで、新時代における医薬品・医療機器開発の精度とスピードを加速し、製品価値の最大化を支援します。

IQVIAは、お客様の様々なニーズにお応えし続けるためにライフサイエンス業界に特化した革新的なソリューションの充実に注力していきます。当社のテクノロジーソリューションは、コンプライアンスを遵守しながらも、医療全体の高度化と業績拡大を目指すお客様を、強力にご支援してまいります。

Clinical Development in Japan

Your Trusted Partner in Japan, the second largest branded pharmaceutical market

Our offerings provide access to all functions and services for partners to successfully navigate the regulatory processes and perform high quality clinical development in Japan.

Locations Japan ソリューション／サービス Clinical Development in Japan

In-Country Clinical Caretaker Services (ICCC)

The In-Country Clinical Caretaker (ICCC) is the representative of the company who sponsors the clinical trial and ensures that procedures are followed as per regulations. IQVIA has very rich experience to support over 100 ICCC clinical trials. IQVIA successfully passed all inspections and contributed to getting partner’s products approved for marketing while acting as the ICCC. This is mandatory for biopharmaceutical companies based outside of Japan who are intending to perform clinical studies in Japan.

Clinical Development in Japan

Your Trusted Partner in Japan, the second largest branded pharmaceutical market

In-Country Clinical Caretaker Services (ICCC)

Japan Regulatory Circumstance for Clinical Trials

Cell and Gene Therapy (CAGT) Clinical Development in Japan

CNS Clinical Development in Japan

Oncology Clinical Development in Japan

Japan Market and IQVIA Japan's Capability

Clinical Development in Japan

Your Trusted Partner in Japan, the second largest branded pharmaceutical market

In-Country Clinical Caretaker Services (ICCC)

Learn More

Japan Regulatory Circumstance for Clinical Trials

Cell and Gene Therapy (CAGT) Clinical Development in Japan

CNS Clinical Development in Japan

Oncology Clinical Development in Japan

Japan Market and IQVIA Japan's Capability